Net Cash Provided by (Used in) Operating Activities |
15.7M |
USD |
-60.6% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-60M |
USD |
-17401% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-1.1M |
USD |
+88.3% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
250M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
37.1M |
shares |
+0.59% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
208M |
USD |
-27.5% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
215K |
USD |
+21.5% |
Dec 31, 2022 |
Q4 2022 |
Deferred Tax Assets, Valuation Allowance |
440M |
USD |
-1.62% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
491M |
USD |
-4.14% |
Dec 31, 2023 |
Q4 2023 |
Payments to Acquire Property, Plant, and Equipment |
1.12M |
USD |
-88% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
14M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
373M |
USD |
-0.21% |
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
12M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
1.01B |
USD |
-12.2% |
Mar 31, 2024 |
Q1 2024 |
Current State and Local Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Depreciation, Depletion and Amortization |
5.75M |
USD |
+13.4% |
Mar 31, 2024 |
Q1 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
1.96M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |